Sinntaxis
Phase 2Sinntaxis - discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke
Founded
2017
Focus
Small Molecules
About
Sinntaxis - discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke
Company Info
TypePrivate
Founded2017
LocationStockholm, Sweden
StagePhase 2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile